BIT 6.25% 4.5¢ biotron limited

$10 Billion Deal, page-141

  1. 16,258 Posts.
    lightbulb Created with Sketch. 742
    "Significant Immunological Outcomes in BIT225 HIV-1 Clinical Trial "

    Can someone explain how they came to this conclusion in a short time frame after treatment based on 27 patients with half on placebo. The variability of data on such a small patient population looking at immune system ages and neurocognitive disorder is going to give you non conclusive data imo. Longer term data on over 300 patients in a phase 2b study can only give any significant results. IMO the reported results are a beat up to get the 6c options exercised.


    "These include an immune system ages more quickly, and there are other problems such as HIV-associated neurocognitive disorder (also known as AIDS-related dementia).
    Last edited by malmanu: 13/11/18
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
4.5¢
Change
-0.003(6.25%)
Mkt cap ! $40.60M
Open High Low Value Volume
4.9¢ 4.9¢ 4.4¢ $178.8K 3.841M

Buyers (Bids)

No. Vol. Price($)
5 95490 4.4¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 50000 1
View Market Depth
Last trade - 16.10pm 20/06/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.